Haisco Pharmaceutical Group Co., Ltd.

This study tested whether adding HSK39297 tablets could help PNH patients who still experience anemia despite being on standard anti-C5 antibody therapy. The trial involved 36 adults with PNH who had low hemoglobin levels despite stable treatment. Researchers measured whether the…

This completed Phase 3 trial tested if a new oral tablet called HSK39297 could work as well as the standard injected drug (eculizumab) for people with a rare blood disease called PNH who had never tried this type of medicine before. The main goal was to see if the pill could safe…

This study tested whether a new oral drug called HSK31679 could improve liver health in people with NASH, a serious form of fatty liver disease that causes scarring. About 186 Chinese adults with confirmed NASH and moderate liver scarring took either the drug or a placebo pill da…

This study aimed to see if a medication called HSK16149 is safe and effective for long-term use in people with peripheral nerve pain. It followed 301 Chinese patients for 52 weeks (one year) who had already taken part in earlier studies of the drug. Researchers tracked side effec…

This study tested whether a new drug called HSK21542 injection works better or is safer than morphine or a placebo for managing pain after hip replacement surgery. It involved 161 adults who had just undergone surgery and were experiencing significant pain. Researchers compared h…

This early-stage study tested how eating food affects the way the body absorbs and processes a new drug called HSK47388. Fifteen healthy adults took the drug under different conditions: on an empty stomach, right after a low-fat meal, and with a meal after a delay. The main goal …